Alzamend Neuro, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jul 2026Filed 10/09/2026 | Jan 2026Filed 11/03/2026 | Oct 2025Filed 09/12/2025 | Jul 2025Filed 10/09/2026 | Jan 2025Filed 11/03/2026 | Oct 2024Filed 09/12/2025 | Jul 2024Filed 10/09/2025 | Jan 2024Filed 10/03/2025 |
|---|---|---|---|---|---|---|---|---|
| −$3 | −$2.2 | −$1 | −$2.7 | −$1 | −$1.4 | −$1 | −$2.7 | |
| −$0.68 | −$0.58 | −$0.30 | −$1.28 | −$1.75 | −$3.61 | −$11.42 | −$3.77 | |
| 4.5 | 3.8 | 3.4 | 2.1 | 0.6 | 0.4 | — | 0.7 |
Trend